RootPath is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
RootPath has raised $1.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
RootPath's investors include HSG, Baidu Ventures, Matrix Partners China, CDH Investments, Sky9 Capital.
RootPath is headquartered in Cambridge, United States.
RootPath is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
RootPath is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RootPath — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/rootpath. Accessed July 20, 2026.
VCBacked. (2025). RootPath — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/rootpath
{{cite web |title=RootPath — Funding & Investors |url=https://www.vcbacked.co/company/rootpath |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated